Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
6,171
datasets available to search
ShareScore release 0.9.0
Dataset results
6,171 results for “mutant”
Phase III Study to Compare GFH375 and Chemotherapy in Patients With KRAS G12D-Mutant Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT07262567. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Perioperative Encobini in BRAFV600 Mutant Stage III (B/C/D) or Oligometastatic Stage IV Melanoma
ClinicalTrials.gov study NCT05097378. IPD Sharing: NO. Countries: 1. Publications: 0.
Disitamab Vedotin Plus Cadonilimab in Patients With HER2 Mutant Advanced or Metastatic Bile Duct Adenocarcinoma
ClinicalTrials.gov study NCT06383533. IPD Sharing: NO. Countries: 1. Publications: 0.
Icotinib as Consolidation Therapy After Chemoradiotherapy in EGFR-Mutant Stage IIIA-IIIB Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT03396185. IPD Sharing: YES. Countries: 1. Publications: 0.
A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant
ClinicalTrials.gov study NCT01340846. IPD Sharing: Not stated. Countries: 3. Publications: 0.
A Phase 1/2 Study to Evaluate the Safety, Tolerability and PK of JIN-A02 in Patients With EGFR Mutant Advanced NSCLC
ClinicalTrials.gov study NCT05394831. IPD Sharing: NO. Countries: 3. Publications: 0.
MRX-2843 and Osimertinib for the Treatment of Advanced EGFR Mutant Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT04762199. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Icotinib as Neoadjuvant and Adjuvant Therapy in EGFR-mutant Stage IIIB or Oligometastasis Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT03349203. IPD Sharing: YES. Countries: 1. Publications: 0.
Trametinib Plus Anlotinib in Non-G12C KRAS-Mutant NSCLC Patients
ClinicalTrials.gov study NCT04967079. IPD Sharing: NO. Countries: 1. Publications: 0.
Neoadjuvant Osimertinib + Chemotherapy for EGFR-mutant Stage III NSCLC
ClinicalTrials.gov study NCT05011487. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Refametinib(BAY86-9766) in RAS Mutant Hepatocellular Carcinoma (HCC)
ClinicalTrials.gov study NCT01915589. IPD Sharing: Not stated. Countries: 17. Publications: 0.
PDX Models From EGFR Mutant Tumors
ClinicalTrials.gov study NCT03872440. IPD Sharing: NO. Countries: 1. Publications: 0.
EMB-01 in Combination With Osimertinib in Patients With EGFR Mutant Lung Cancer
ClinicalTrials.gov study NCT05498389. IPD Sharing: NO. Countries: 2. Publications: 0.
Exploring Cancer Evolution, Prognostic and Predictive Biomarkers in EGFR-mutant NSCLC
ClinicalTrials.gov study NCT05997719. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery
ClinicalTrials.gov study NCT03943173. IPD Sharing: NO. Countries: 1. Publications: 0.
Mirdametinib in Patients With Advanced NF1-mutant Melanoma
ClinicalTrials.gov study NCT07237100. IPD Sharing: YES. Countries: 1. Publications: 0.
Efficacy and Safety of Tunlametinib Plus Vemurafenib in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT06008119. IPD Sharing: NO. Countries: 1. Publications: 0.
Cancer Therapy-Related Cardiac Dysfunction Associated With EGFR-TKIs in Advanced EGFR-mutant Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT07267247. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
ClinicalTrials.gov study NCT07383506. IPD Sharing: NO. Countries: 0. Publications: 0.
A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation
ClinicalTrials.gov study NCT06789913. IPD Sharing: NO. Countries: 6. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.